152 related articles for article (PubMed ID: 38043067)
1. Simultaneous catheter and multicriteria optimization for HDR cervical cancer brachytherapy with a complex intracavity/interstitial applicator.
Bélanger C; Aubin S; Lavallée MC; Beaulieu L
Med Phys; 2024 Mar; 51(3):2128-2143. PubMed ID: 38043067
[TBL] [Abstract][Full Text] [Related]
2. Analytical HDR prostate brachytherapy planning with automatic catheter and isotope selection.
Frank CH; Ramesh P; Lyu Q; Ruan D; Park SJ; Chang AJ; Venkat PS; Kishan AU; Sheng K
Med Phys; 2023 Oct; 50(10):6525-6534. PubMed ID: 37650773
[TBL] [Abstract][Full Text] [Related]
3. Catheters and dose optimization using a modified CVT algorithm and multi-criteria optimization in prostate HDR brachytherapy.
Chatigny PY; Bélanger C; Poulin É; Beaulieu L
Med Phys; 2022 Oct; 49(10):6575-6587. PubMed ID: 35892205
[TBL] [Abstract][Full Text] [Related]
4. Interstitial round needles should not be used for cervical cancer patient treated with intracavitary/ interstitial brachytherapy using a Venezia applicator : a case report.
Takagawa Y; Izumi S; Takahashi E; Kita M
BMC Womens Health; 2024 Apr; 24(1):249. PubMed ID: 38637783
[TBL] [Abstract][Full Text] [Related]
5. Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy.
Bélanger C; Poulin É; Cui S; Vigneault É; Martin AG; Foster W; Després P; Cunha JAM; Beaulieu L
Brachytherapy; 2020; 19(5):607-617. PubMed ID: 32713779
[TBL] [Abstract][Full Text] [Related]
6. Prospective validation of a machine learning model for applicator and hybrid interstitial needle selection in high-dose-rate (HDR) cervical brachytherapy.
Stenhouse K; Roumeliotis M; Ciunkiewicz P; Martell K; Quirk S; Banerjee R; Doll C; Phan T; Yanushkevich S; McGeachy P
Brachytherapy; 2024; 23(3):368-376. PubMed ID: 38538415
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric evaluation of the feasibility of utilizing a reduced number of interstitial needles in combined intracavitary and interstitial brachytherapy for cervical cancer.
Jahan D; Ahmad S; Thompson S; Schnell E
J Appl Clin Med Phys; 2023 Feb; 24(2):e13833. PubMed ID: 36355039
[TBL] [Abstract][Full Text] [Related]
9. A fast inverse treatment planning strategy facilitating optimized catheter selection in image-guided high-dose-rate interstitial gynecologic brachytherapy.
Guthier CV; Damato AL; Hesser JW; Viswanathan AN; Cormack RA
Med Phys; 2017 Dec; 44(12):6117-6127. PubMed ID: 28921538
[TBL] [Abstract][Full Text] [Related]
10. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy.
Hopfensperger KM; Adams QE; Kim Y; Wu X; Xu W; Patwardhan K; Flynn RT
Med Phys; 2023 Oct; 50(10):6469-6478. PubMed ID: 37643427
[TBL] [Abstract][Full Text] [Related]
11. A novel intra pre-plan method of interstitial needle optimization for cervical cancer patients treated with Venezia applicator brachytherapy: a technical note.
Takagawa Y; Tsuchiya K; Izumi S; Okano T; Takahashi E; Wakamatsu Y; Kamoshida K; Miyake Y; Kita M
J Contemp Brachytherapy; 2022 Jun; 14(3):260-267. PubMed ID: 36199991
[TBL] [Abstract][Full Text] [Related]
12. Dosimetric considerations when utilizing Venezia, Capri, Rotte double tandem, and tandem and ring with interstitial needles for the treatment of gynecological cancers with high dose rate brachytherapy.
Schnell E; Thompson S; Ahmad S; Herman TS; De La Fuente Herman T
Med Dosim; 2020 Spring; 45(1):21-27. PubMed ID: 31101569
[TBL] [Abstract][Full Text] [Related]
13. Inter-observer evaluation of a GPU-based multicriteria optimization algorithm combined with plan navigation tools for HDR brachytherapy.
Bélanger C; Poulin É; Aubin S; Vigneault É; Martin AG; Foster W; Beaulieu L
Brachytherapy; 2022; 21(4):551-560. PubMed ID: 35585019
[TBL] [Abstract][Full Text] [Related]
14. Adaptive method for multicriteria optimization of intensity-modulated proton therapy.
Kamal-Sayed H; Ma J; Tseung H; Abdel-Rehim A; Herman MG; Beltran CJ
Med Phys; 2018 Dec; 45(12):5643-5652. PubMed ID: 30332515
[TBL] [Abstract][Full Text] [Related]
15. Outcomes and comparison of dosimetric parameters between intracavitary (Fletcher) and combined intracavitary/interstitial (Utrecht) brachytherapy in locally advanced cervical cancer.
Sarwar KA; Hussain S; Syed AS; Khan K; Maqsood T; Azeem T
Brachytherapy; 2024; 23(1):10-17. PubMed ID: 37813708
[TBL] [Abstract][Full Text] [Related]
16. Development of patient and catheter specific error thresholds for high dose rate prostate brachytherapy.
Koprivec D; Belanger C; Beaulieu L; Chatigny PY; Rosenfeld A; Cutajar D; Petasecca M; Howie A; Bucci J; Poder J
Med Phys; 2024 Mar; 51(3):2144-2154. PubMed ID: 38308854
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous needle catheter selection and dwell time optimization for preplanning of high-dose-rate brachytherapy of prostate cancer.
Wang C; Gonzalez Y; Shen C; Hrycushko B; Jia X
Phys Med Biol; 2021 Mar; 66(5):055028. PubMed ID: 33264753
[TBL] [Abstract][Full Text] [Related]
18. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
[TBL] [Abstract][Full Text] [Related]
19. Radiobiological and dosimetric comparison of 60Co versus 192Ir high-dose-rate intracavitary-interstitial brachytherapy for cervical cancer.
Wen A; Wang X; Wang B; Yan C; Luo J; Wang P; Li J
Radiat Oncol; 2022 Dec; 17(1):206. PubMed ID: 36514118
[TBL] [Abstract][Full Text] [Related]
20. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
